Want to learn more about diabetes management?

Don’t miss Angi Thompson, DNP, FNP-C, BC-ADM, CDE, FAANP on Saturday, October 20, 2018 from 8–9 a.m., as she presents the latest information on the titratable fixed-ratio combination therapies with basal insulin/GLP1-RA and addresses best practices to implement and intensify this treatment in your patients. Faculty and a patient with T2DM will present key concepts to overcome common provider and patient barriers to implementing injectable therapy.

Deepen your knowledge and competence of current diabetes guidelines and the physiologic approach to diabetes management and improve the quality of the health and life or your patients with T2DM.

LEARNING OBJECTIVES:
• Compare and contrast current guidelines for patients with type 2 diabetes mellitus (T2DM) not at goal.
• Review data on combination GLP-1 RAs and basal insulin for individuals with T2DM when intensification is needed.
• Identify how fixed-dose combination therapy with GLP1-RA and insulin can help patients achieve glycemic goals.
• Formulate strategies to overcome barriers to the introduction and intensification of fixed ratio therapies.

Click here for the flyer.

For all things Statewide Conference, follow our blog.